The presentation will use metabolomics as a data construct to highlight the importance of standardization of both protocols and data to enable data-driven analytics for the creation of actionable solutions. A case study will be presented on the use of metabolomics data for target identification and validation of its potential clinical utility as a pathway for drug discovery.